Humanaut Health

Humanaut turns a diagnostic day into a year-long care cadence. Path members start with broad biomarker testing plus DEXA, VO2 max, CIMT, and grip-strength assessment, then review results quarterly with an APRN. Bond members move into a physician-led track with more testing depth, a five-person care team, weekly coaching, monthly doctor consults, and tighter access between visits. The service menu is clinic-based, so the diagnostics, consults, and regenerative therapies are meant to sit under one membership relationship rather than a one-off lab order.

• Operator plus clinician founding team. Jim Donnelly brings the Restore Hyper Wellness scaling playbook; Amy Killen, MD and Harry Adelson, ND bring hormone, regenerative, and stem-cell medicine depth. - Clear two-track membership model. Path gives members a published $2,700/yr APRN-led entry point; Bond is a higher-touch physician-led tier with broader testing and coaching. - Regenerative care stays in-house. Stem-cell therapy, TPE, EBO2, peptides, hormones, IV therapy, and recovery modalities sit inside the clinic network instead of being sent to unrelated providers. - Multi-location growth path. Austin is the flagship, Palm Beach Gardens gives Humanaut a Florida foothold, Dallas is scheduled for May 2026, and the company is actively building a franchise pipeline.

• Self-pay model. Humanaut does not bill insurance. HSA/FSA may apply to eligible diagnostics or prescribed therapies, but membership fees usually need separate benefits confirmation. - Path is annual. The published $225/mo price is billed annually at $2,700/yr. - Bond pricing is not published. Expect a consultation before Humanaut shares pricing for the physician-led tier. - Care is clinic-based. Messaging and prescription management continue between visits, but this is not a telehealth-only product. - Procedures add cost. Stem-cell therapy, TPE, EBO2, peptides, hormone protocols, IVs, and other therapies are quoted separately unless included in a specific membership offer.